{"id":"https://openalex.org/W4324017686","doi":"https://doi.org/10.1007/s40262-023-01236-4","title":"Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment","display_name":"Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment","publication_year":2023,"publication_date":"2023-03-13","ids":{"openalex":"https://openalex.org/W4324017686","doi":"https://doi.org/10.1007/s40262-023-01236-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/36913139","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10085895"},"language":"en","primary_location":{"id":"doi:10.1007/s40262-023-01236-4","doi":"https://doi.org/10.1007/s40262-023-01236-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-023-01236-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-023-01236-4.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"erratum","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40262-023-01236-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002259460","display_name":"Mikkel Askj\u00e6r Agersnap","orcid":"https://orcid.org/0000-0002-5827-5870","observed_orcids":["https://orcid.org/0000-0002-5827-5870"]},"institutions":[{"id":"https://openalex.org/I4210096064","display_name":"Zealand Pharma (Denmark)","ror":"https://ror.org/00tf97v72","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210096064"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Mikkel Askj\u00e6r Agersnap","raw_affiliation_strings":["Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark. miagersnap@gmail.com","Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark"],"raw_orcid":"https://orcid.org/0000-0002-5827-5870","affiliations":[{"raw_affiliation_string":"Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark. miagersnap@gmail.com","institution_ids":["https://openalex.org/I4210096064"]},{"raw_affiliation_string":"Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I4210096064"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057371552","display_name":"Kim Sonne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096064","display_name":"Zealand Pharma (Denmark)","ror":"https://ror.org/00tf97v72","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210096064"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Kim Sonne","raw_affiliation_strings":["Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I4210096064"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102131746","display_name":"Kim Mark Knudsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096064","display_name":"Zealand Pharma (Denmark)","ror":"https://ror.org/00tf97v72","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210096064"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Kim Mark Knudsen","raw_affiliation_strings":["Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zealand Pharma A/S, Sydmarken 11, 2860, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I4210096064"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080886481","display_name":"W\u0142adys\u0142aw Su\u0142owicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wladyslaw Sulowicz","raw_affiliation_strings":["SCM Sp\u00f3\u0142ka z o.o., Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCM Sp\u00f3\u0142ka z o.o., Krakow, Poland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002259460"],"corresponding_institution_ids":["https://openalex.org/I4210096064"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"62","issue":"4","first_page":"653","last_page":"654"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-2-analog","display_name":"GLP-2 analog","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8529999852180481},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8009999990463257},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.875},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8272236585617065},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7620970606803894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.703301191329956},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4906083643436432},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4835750460624695},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38837674260139465},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3396015167236328},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.301194429397583}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s40262-023-01236-4","doi":"https://doi.org/10.1007/s40262-023-01236-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-023-01236-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-023-01236-4.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10085895","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10085895","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10085895/pdf/40262_2023_Article_1236.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacokinet","raw_type":"Text"},{"id":"pmid:36913139","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36913139","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacokinetics","raw_type":"Published Erratum"}],"best_oa_location":{"id":"doi:10.1007/s40262-023-01236-4","doi":"https://doi.org/10.1007/s40262-023-01236-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-023-01236-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-023-01236-4.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4324017686.pdf","grobid_xml":"https://content.openalex.org/works/W4324017686.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4321437501","https://openalex.org/W4249556971","https://openalex.org/W3174937546","https://openalex.org/W3216541849","https://openalex.org/W2808081808","https://openalex.org/W4392654922","https://openalex.org/W2405316360","https://openalex.org/W4387660914","https://openalex.org/W3216204326","https://openalex.org/W2140536043"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-03-14T00:00:00"}